( An ISO 9001:2015 Certified International Journal )

An International Peer Reviewed Journal for Pharmaceutical, Medical & Biological Sciences

An Official Publication of Society for Advance Healthcare Research (Reg. No. : 01/01/01/31674/16)

European Journal of Pharmaceutical and Medical Research (EJPMR) has indexed with various reputed international bodies like : Google Scholar , Indian Science Publications , InfoBase Index (In Process) , SOCOLAR, China , Research Bible, Fuchu, Tokyo. JAPAN , International Society for Research activity (ISRA) , Scientific Indexing Services (SIS) , Polish Scholarly Bibliography , Global Impact Factor (GIF) (Under Process) , Universal Impact Factor , International Scientific Indexing (ISI), UAE  , Index Copernicus , CAS (A Division of American Chemical Society) USA (Under Process) , Directory of Open Access Journal (DOAJ, Sweden, in process) , UDLedge Science Citation Index , CiteFactor , Directory Of Research Journal Indexing (DRJI) , Indian citation Index (ICI) , Journal Index (JI, Under Process) , Directory of abstract indexing for Journals (DAIJ) , Open Access Journals (Under Process) , Impact Factor Services For International Journals (IFSIJ) , Cosmos Impact Factor , Jour Informatics (Under Process) , Eurasian Scientific Journal Index (ESJI) , International Innovative Journal Impact Factor (IIJIF) , Science Library Index, Dubai, United Arab Emirates , Pubmed Database [NLM ID: 101669306] (Under Process) , IP Indexing (IP Value 2.40) , Web of Science Group (Under Process) , Directory of Research Journals Indexing , Scholar Article Journal Index (SAJI) , International Scientific Indexing ( ISI ) , Scope Database , 

 ISSN 2394-3211

Impact Factor: 6.222

 ICV - 79.57



Dr. Roopendra Singh Bhati* and Prof. A. Rama Murthy


The SARS-CoV-2 virus is the infectious disease known as coronavirus disease (COVID-19). SARS-CoV-2 severe acute respiratory syndrome has developed into a pandemic. Being a novel virus, the pathogenesis of the disease causation is not fully understood, and drugs against this virus are still being tested, Consequently, there isn't an effective treatment at the moment. The research finding suggests that many Ayurved herbal drugs possess immune-modulatory, anti-inflammatory, and antiviral properties can be a turning point in the prevention and management of COVID-19. Reviewing the role of immunity in the pathogenesis of COVID-19, as well as ‘Giloy kwath’ and ‘Ayush Kwath’ significance in combating the virus and the regulation of immunity, is our intent in this literature study. The current review was carried out using a search of the available literature on COVID-19 and immunity, Ayurveda and COVID-19, Vyadhikshamatwa, Rasayana, and immunomodulatory effects of medicinal plants, including Guduchi (Tinospora cordifolia Willd.) Sunthi/Ginger(Zingiber officinale Rosc.), Marich/Black Pepper/(Piper nigrum Linn.), Dalchini (Cinnamomum zeylanicum Breyn.) and Tulsi/Holy Basil(Ocimum sanctum Linn.). Since ancient times, ayurveda and traditional remedies have significantly aided in the prevention and treatment of numerous communicable and noncommunicable diseases. Numerous therapeutic methods, such as Rasayana, Satwawajaya, Yuktivyapashraya, Vyadhi Viparitarthakari chikitsa, etc. can be used to accomplish Guduchi kwath and Ayush Kwath immune-promoting and disease-alleviating characteristics. Guduchi kwath as well as Ayush Kwath appears to be useful in regulating immunity for the prevention and mitigation of viral illness sequelae because of its antipyretic, antiviral, immune-modulatory, antioxidant, anti-inflammatory, anti-platelet, anti-atherosclerotic, hepatoprotective, and reno-protective qualities. The efficiency of these formulations must be confirmed via substantial biotechnological, pharmacological, and clinical research because there is insufficient data to establish their specific role against coronavirus.

Keywords: .

[Full Text Article]



  • New Issue Published

    Its Our pleasure to inform you that, EJPMR 1 September 2023 Issue has been Published, Kindly check it on


    SEPTEMBER issue has been successfully launched on 1 SEPTEMBER 2023.

  • EJPMR New Impact Factor

    Its our Pleasure to Inform you that EJPMR Impact Factor has been increased from  5.804 to 6.222, due to high quality Publication at International Level

  • Index Copernicus Value

    EJPMR Received Index Copernicus Value 79.57, due to High Quality Publication in EJPMR at International Level

  • Journal web site support Internet Explorer, Google Chrome, Mozilla Firefox, Opera, Saffari for easy download of article without any trouble.


  • Article Invited for Publication

    Article are invited for publication in EJPMR Coming Issue

Google Scholar Indian Science Publications InfoBase Index (In Process) SOCOLAR, China Research Bible, Fuchu, Tokyo. JAPAN International Society for Research activity (ISRA) Scientific Indexing Services (SIS) Polish Scholarly Bibliography Global Impact Factor (GIF) (Under Process) Universal Impact Factor International Scientific Indexing (ISI), UAE Index Copernicus CAS (A Division of American Chemical Society) USA (Under Process) Directory of Open Access Journal (DOAJ, Sweden, in process) UDLedge Science Citation Index CiteFactor Directory Of Research Journal Indexing (DRJI) Indian citation Index (ICI) Journal Index (JI, Under Process) Directory of abstract indexing for Journals (DAIJ) Open Access Journals (Under Process) Impact Factor Services For International Journals (IFSIJ) Cosmos Impact Factor Jour Informatics (Under Process) Eurasian Scientific Journal Index (ESJI) International Innovative Journal Impact Factor (IIJIF) Science Library Index, Dubai, United Arab Emirates Pubmed Database [NLM ID: 101669306] (Under Process) IP Indexing (IP Value 2.40) Web of Science Group (Under Process) Directory of Research Journals Indexing Scholar Article Journal Index (SAJI) International Scientific Indexing ( ISI ) Scope Database